The European Union requires companies to comply with the Medical Devices Directive in order to sell medical devices in its 27 member countries; the CE mark is evidence that ClearCount and its product offerings meet the requirements of these directives.
The SmartSponge product line is the first and only RFID-based surgical safety and efficiency technology bearing a CE mark, according to the release. The SmartSponge System identifies each sponge in an operating room so they can be both counted and detected during surgery.
“We have established a perfect safety record over the past two years in the United States. Our hospital customers have never experienced a retained surgical sponge while using our technology,” said David Palmer, chief executive officer of ClearCount, in the release. “CE mark approval of our SmartSponge System and SmartWand-DTX represents a significant achievement and major milestone for our company.”
More Articles Featuring ClearCount:
Medline Signs Agreement With Premier for ClearCount Surgical Safety Technology
10 Things to Know About Retained Surgical Sponges
ClearCount Medical Announces FDA Clearance of SmartWand-DTX System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
